Metronidazole Capsule Market, Size, Share, Growth, Trends, Insight and Industry Forecast, 2021-2028

SKU: DMPH3746 | Last Updated On: Aug 30 2021 | No. of Pages: 180 | Available Formats

> Global Metronidazole Capsule Market Expected to reach a high CAGR By 2028: DataM Intelligence

Global  Metronidazole Capsule Market is segmented By Distribution Channel (Offline, Online), By Product Type (Prescriptions, OTC), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

Market Overview

The metronidazole capsule market size was valued at US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028). 

An antibiotic that is used to treat a wide variety of infections is Metronidazole. Metronidazole helps to stop the growth of certain parasites and bacteria.This antibiotic treats only certain bacterial and parasitic infections.

Source: DataM Intelligence Analysis (2020)

 Market Dynamics

The increasing prevalence of parasitic and bacterial infections will drive the Metronidazole Capsule Market The widespread use of medication in combination with other antibiotics will drive market growth.

The increasing prevalence of parasitic and bacterial infections will drive the metronidazole capsule market

It is estimated that about 1–10% of the world’s population is infected with scabies, and in some crowded regions with unhygienic conditions, the prevalence might be as high as 50%. Pediculosis is also a common infestation, particularly among children.

Metronidazole is an antibiotic. It's used to treat rosacea, skin infections and mouth infections (including infected gums and dental abscesses). It's used in the treatment of conditions such as pelvic inflammatory disease and bacterial vaginosis. It's also used to treat infected insect bites, skin ulcers, bedsores, and wounds and treat and prevent bacterial and parasitic infections. Flagyl is an antibiotic effective against anaerobic bacteria and certain parasites. Flagyl and Flagyl ER are the brand names available for metronidazole in the US. It is used to treat parasitic infections  including amebic liver abscess, giardia infections of the small intestine and amebic dysentery (infection of the colon causing bloody diarrhea), bacterial vaginosis, trichomonas vaginal infections, and carriers of trichomonas (both sexual partners) who do not have symptoms of infection.

The widespread use of medication in combination with other antibiotics will drive the market growth

A combination of amoxicillin (AMX) and metronidazole (MET)  is commonly used as an adjunct to mechanical therapy of periodontal disease. The use of broad-spectrum antibiotics such as AMX may contribute to the development of antibiotic resistance.

Ciprofloxacin has reduced activity against anaerobic pathogens. Therefore, a combination of ciprofloxacin with an antimicrobial agent active against anaerobes, such as metronidazole, seems to be interesting for treating mixed aerobic/anaerobic infections. High metronidazole concentrations (10 mg/l or 40 mg/l) neither affected the bactericidal efficacy of ciprofloxacin on aerobic pathogens, such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis, nor on the anaerobic pathogens Clostridium perfringens and Clostridium difficile, as demonstrated by kill-kinetic curves. The same high concentrations and lower therapeutically achievable concentrations (2 mg/l or five mg/l) of metronidazole in combination with ciprofloxacin were slightly more potent for the tested clostridia than ciprofloxacin or metronidazole alone.

The side effects associated with its use will hamper the metronidazole capsule market

Dizziness, headache, stomach upset, nausea, vomiting, loss of appetite, diarrhea, constipation, or metallic taste in the mouth may occur. This medication may cause your urine to turn darker in color. This effect is harmless and will disappear when the medication is stopped. Usage of this medication for prolonged or repeated periods may result in oral thrush or a new yeast infection. Metronidazole can cause life-threatening liver problems in people with Cockayne syndrome.

The serious adverse reactions reported in patients treated with metronidazole have been encephalopathy, convulsive seizures, optic and peripheral neuropathy, aseptic meningitis, the latter characterized mainly by paresthesia or numbness of an extremity. Since persistent peripheral neuropathy has been reported in some patients receiving prolonged administration of metronidazole, patients should be specifically warned about these reactions. They should be told to stop the drug and report immediately to their physicians if any neurologic symptoms occur. In addition, patients have reported headaches, syncope, dizziness, vertigo, incoordination, ataxia, confusion, dysarthria, irritability, depression, weakness, and insomnia.

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry. To curb its growth, government-imposed lockdown. People are fearful they will experience occupational effects and adverse health from the COVID-19 pandemic. This has seen to affect the metronidazole capsule market as many pharmaceutical industries have stopped manufacturing units.

Segment Analysis

The offline segment is expected to dominate the metronidazole capsule market in the forecast period

This segment will see growth due to the consumer preference for buying medicines from a pharmacy or drug store. The pharmacist verifies the legality, safety, and appropriateness of the prescription order, checks the patient medication record before dispensing the prescription (when such records are kept in the pharmacy), ensures that the quantities of medication are dispensed accurately, and decides whether the medication should be handed to the patient with appropriate counselling.

In addition to fulfilling prescriptions, a pharmacy might offer preventive healthcare services like vaccinations. Up-to-date technology at a pharmacy can assist a patient with prescription reminders and alerts about potential negative drug interactions, thereby reducing medical errors. Hence, this segment will see growth in the forecast period.

The prescription segment will dominate the metronidazole capsule market

Metronidazole belongs to a class of medications known as nitroimidazole drugs. Metronidazole is an antibacterial medication used to treat or prevent infections that are strongly suspected or proven to be caused by bacteria, especially microorganisms susceptible to metronidazole. Metronidazole prescription medication also has antiprotozoal properties - similar to nitazoxanide (Alinia). More specifically, metronidazole is typically indicated to treat some cases of bacterial vaginosis, trichomoniasis, amebiasis, and anaerobic bacterial infections.

 Metronidazole has amebicidal and trichomonacidal against T. vaginalis and E. histolytica. Metronidazole is active against most obligate anaerobes and typically has a bactericidal effect at or above the minimal inhibitory concentration. Metronidazole is often prescribed as either metronidazole two grams or metronidazole 250 mg three times per day for seven days to treat trichomoniasis. In the United States metronidazole is a prescription medication. Because of this, metronidazole OTC (over-the-counter) is not available from pharmacies, and one cannot just buy metronidazole online.

Geographical Analysis

North America region will dominate the metronidazole capsule market

With increased research and development activity and the presence of major key players, this region will dominate the Metronidazole Capsule Market

84.5 million Americans — one in four — were impacted by skin disease. Skin disease costs the US health care system $75 billion in medical, preventative, and prescription and non-prescription drug costs. Every year, at least 2 million people are infected with antibiotic-resistant bacteria, and about 23,000 succumb to the infection in the US.

In 2018, it was the 119th most commonly prescribed medication in the United States, with more than 5 million prescriptions. Pharma Major Lupin has received its final approval for its Metronidazole Tablets USP, 250 mg and 500 mg from the United States Food and Drug Administration (FDA) to market a generic version of G.D. Searle LLC’s Flagyl® Tablets, 250 mg, and 500 mg. Aurobindo Pharma has received US health regulator’s approval to manufacture and market Metronidazole tablets, used to treat various kinds of infections, in the US market.

Source: DataM Intelligence Analysis (2020)

Competitive Landscape

Major key players in the metronidazole capsule market are Hongyuan Pharmaceutical, Yinhe Aarti Pharmaceutical, Aarti Drugs, Yichang Changjiang Pharmaceutical, Saikang Pharmaceutical, Unichem Laboratories, CordenPharma Farchemia, Tongji Pharmaceutical, Wuyao Pharmaceutical, and API Polpharma

Metronidazole Capsule Market Key Companies to Watch

Aarti Drugs

Overview: The Company is engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and producing Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited.The Company over the years has been able to carve a niche for itself and is looking forward to expanding the volumes. With the government initiative to encourage private health insurance schemes, consumer spending on medicines is expected to increase, spur growth in the generic sector in the domestic market.

Product Portfolio: The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs). Products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin, etc., whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate, etc.

Key Development: Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs, has received approval accorded under Production Linked Incentive (PLI) scheme for the pharmaceutical sector.

Why Purchase the Report?

  • Visualize the composition of the metronidazole capsule market segmentation By Distribution Channel and Product type highlighting the key commercial assets and players.
  • Identify commercial opportunities in metronidazole capsule market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of metronidazole capsule market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The metronidazole capsule market report would provide an access to an approx. 53 market data table, 40 figures and 200 pages. 

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Metronidazole Capsule Market- By Distribution Channel

  • Offline
  •  Online

Metronidazole Capsule Market- By Product Type

  • Prescription
  • OTC

Metronidazole Capsule Market- By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

  1. Metronidazole Capsule Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Metronidazole Capsule Market– Market Definition and Overview

  3. Metronidazole Capsule Market– Executive Summary

    1. Market Snippet By Distribution Channel
    2. Market Snippet By Product Type
    3. Market Snippet by Region
  4. Metronidazole Capsule Market-Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. The increasing prevalence of bacterial and parasitic infections will drive the metronidazole capsule market
        2. The widespread use of medication in combination with other antibiotics will drive the market growth
      2. Restraints:
        1. Side effects associated with its use will hamper the metronidazole capsule market
      3. Opportunity
      4. Impact Analysis
  5. Metronidazole Capsule Market– Industry Analysis

    1. Porter's Five Forces Analysis
    2. Epidemiology Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
    5. Regulatory Analysis
    6. Reimbursement Analysis
    7. Unmet Needs
  6. Metronidazole Capsule Market– COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Metronidazole Capsule Market– By Distribution Channel

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
      2. Market Attractiveness Index, By Distribution Channel Segment
    2. Offline *
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3.  Online
  8. Metronidazole Capsule Market– By Product Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
      2. Market Attractiveness Index, By Product Type Segment
    2. Prescriptions *
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. OTC
  9. Metronidazole Capsule Market– By Region

    1. Introduction
      1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  10. Metronidazole Capsule Market– Competitive Landscape

    1. Key Developments and Strategies
    2. Company Share Analysis
    3. Product Benchmarking
    4. Key Companies to Watch
    5. Company with disruptive technology
    6. Start Up Companies
  11. Metronidazole Capsule Market- Company Profiles

    1. Aarti Drugs*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Hongyuan Pharmaceutical
    3. Yinhe Aarti Pharmaceutical
    4. Yichang Changjiang Pharmaceutical
    5. Saikang Pharmaceutical
    6. Unichem Laboratories
    7. CordenPharma Farchemia
    8. Tongji Pharmaceutical
    9. Wuyao Pharmaceutical
    10. API Polpharma(*LIST NOT EXHAUSTIVE)
  12. Metronidazole Capsule Market– DataM  

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

List of Tables

Table 01 Metronidazole Capsule MarketValue, By Distribution Channel, 2020, 2024 & 2028($ Million)

Table 02 Metronidazole Capsule MarketValue, By Product Type, 2020, 2024 & 2028($ Million)

Table 03 Metronidazole Capsule MarketValue, By Region, 2020, 2024 & 2028($ Million)

Table 04 Metronidazole Capsule MarketValue, By Distribution Channel, 2020, 2024 & 2028($ Million)

Table 05 Metronidazole Capsule MarketValue, By Distribution Channel, 2018-2028 ($ Million)

Table 06 Metronidazole Capsule MarketValue, By Product Type, 2020, 2024 & 2028($ Million)

Table 07 Metronidazole Capsule MarketValue, By Product Type, 2018-2028 ($ Million)

Table 08  Metronidazole Capsule MarketValue, By Region, 2020, 2024 & 2028($ Million)

Table 09 Metronidazole Capsule MarketValue, By Region, 2018-2028 ($ Million)

Table 10 North America Metronidazole Capsule MarketValue, By Distribution Channel, 2018-2028 ($ Million)

Table 11  North America Metronidazole Capsule MarketValue, By Product Type, 2018-2028 ($ Million)

Table 12 North America Metronidazole Capsule MarketValue, By Country, 2018-2028 ($ Million)

Table 13 South America Metronidazole Capsule MarketValue, By Distribution Channel, 2018-2028 ($ Million)

Table 14 South America Metronidazole Capsule MarketValue, By Product Type, 2018-2028 ($ Million)

Table 15 South America Metronidazole Capsule MarketValue, By Country, 2018-2028 ($ Million)

Table 16 Europe Metronidazole Capsule MarketValue, By Distribution Channel, 2018-2028 ($ Million)

Table 17  Europe Metronidazole Capsule MarketValue, By Product Type, 2018-2028 ($ Million)

Table 18 Europe Metronidazole Capsule MarketValue, By Country, 2018-2028 ($ Million)

Table 19 Asia-Pacific Metronidazole Capsule MarketValue, By Distribution Channel, 2018-2028 ($ Million)

Table 20 Asia-Pacific Metronidazole Capsule MarketValue, By Product Type, 2018-2028 ($ Million)

Table 21 Asia-Pacific Metronidazole Capsule MarketValue, By Country, 2018-2028 ($ Million)

Table 22 Middle East & Africa Metronidazole Capsule MarketValue, By Distribution Channel, 2018-2028 ($ Million)

Table 23 Middle East & Africa Metronidazole Capsule MarketValue, By Product Type, 2018-2028 ($ Million)

Table 24 Aarti Drugs: Overview

Table 25 Aarti Drugs: Product Portfolio

Table 26 Aarti Drugs: Key Developments

Table 27 Hongyuan Pharmaceutical: Overview

Table 28 Hongyuan Pharmaceutical: Product Portfolio

Table 29 Hongyuan Pharmaceutical: Key Developments

Table 30 Yinhe Aarti Pharmaceutical: Overview

Table 31 Yinhe Aarti Pharmaceutical: Product Portfolio

Table 32 Yinhe Aarti Pharmaceutical: Key Developments

Table 33 Yichang Changjiang Pharmaceutical: Overview

Table 34 Yichang Changjiang Pharmaceutical: Product Portfolio

Table 35 Yichang Changjiang Pharmaceutical: Key Developments

Table 36 Saikang Pharmaceutical: Overview

Table 37 Saikang Pharmaceutical: Product Portfolio

Table 38 Saikang Pharmaceutical: Key Developments

Table 39 Unichem Laboratories: Overview

Table 40 Unichem Laboratories: Product Portfolio

Table 41 Unichem Laboratories: Key Developments

Table 42 CordenPharma Farchemia  Overview

Table 43 CordenPharma Farchemia : Product Portfolio

Table 44 CordenPharma Farchemia : Key Developments

Table 45 Tongji Pharmaceutical: Overview

Table 46 Tongji Pharmaceutical: Product Portfolio

Table 47 Tongji Pharmaceutical: Key Developments

Table 48 Wuyao Pharmaceutical .: Overview

Table 49 Wuyao Pharmaceutical .: Product Portfolio

Table 50 Wuyao Pharmaceutical .: Key Developments

Table 51 API Polpharma: Overview

Table 52 API Polpharma: Product Portfolio

Table 53 API Polpharma: Key Developments

   List of Figures

Figure 01 Metronidazole Capsule MarketShare, By Distribution Channel, 2020 & 2028(%)

Figure 02 Metronidazole Capsule MarketShare, By Product Type, 2020 & 2028(%)

Figure 03 Metronidazole Capsule MarketShare, By Region, 2020 & 2028(%)

Figure 04 Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 05 Metronidazole Capsule MarketY-o-Y Growth, By Distribution Channel, 2020-2028 (%)

Figure 06 Offline: Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 07 Online: Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 08          Metronidazole Capsule MarketY-o-Y Growth, By Product Type, 2020-2028 (%)

Figure 09 Prescriptions: Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 10 OTC: Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 11  Metronidazole Capsule MarketY-o-Y Growth, By Region, 2020-2028 (%)

Figure 12 North America Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 13 North America Metronidazole Capsule MarketShare, By Distribution Channel, 2020 & 2028(%)

Figure 14 North America Metronidazole Capsule MarketShare, By Product Type, 2020 & 2028(%)

Figure 15 North America Metronidazole Capsule MarketShare, By Country, 2020 & 2028(%)

Figure 16 South America Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 17  South America Metronidazole Capsule MarketShare, By Distribution Channel, 2020 & 2028(%)

Figure 18 South America Metronidazole Capsule MarketShare, By Product Type, 2020 & 2028(%)

Figure 19 South America Metronidazole Capsule MarketShare, By Country, 2020 & 2028(%)

Figure 20 Europe Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 21 Europe Metronidazole Capsule MarketShare, By Distribution Channel, 2020 & 2028(%)

Figure 22 Europe Metronidazole Capsule MarketShare, By Product Type, 2020 & 2028(%)

Figure 23 Europe Metronidazole Capsule MarketShare, By Country, 2020 & 2028(%)

Figure 24 Asia-Pacific Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 25 Asia-Pacific Metronidazole Capsule MarketShare, By Distribution Channel, 2020 & 2028(%)

Figure 26 Asia-Pacific Metronidazole Capsule MarketShare, By Product Type, 2020 & 2028(%)

Figure 27 Asia-Pacific Metronidazole Capsule MarketShare, By Country, 2020 & 2028(%)

Figure 28 Middle East & Africa Metronidazole Capsule MarketValue, 2018-2028 ($ Million)

Figure 29 Middle East & Africa Metronidazole Capsule MarketShare, By Distribution Channel, 2020 & 2028(%)

Figure 30 Middle East & Africa Metronidazole Capsule MarketShare, By Product Type, 2020 & 2028(%)

Figure 31 Aarti Drugs: Financials

Figure 32 Hongyuan Pharmaceutical: Financials

Figure 33 Yinhe Aarti Pharmaceutical: Financials

Figure 34 Yichang Changjiang Pharmaceutical: Financials

Figure 35 Saikang Pharmaceutical: Financials

Figure 36 Unichem Laboratories: Financials

Figure 37 CordenPharma Farchemia  Financials

Figure 38 Tongji Pharmaceutical: Financials

Figure 39 Wuyao Pharmaceutical .: Financials

Figure 40 API Polpharma: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your free sample proposal with a single click!

linkedinpinterest